These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15194334)

  • 1. Risk factors associated with cytomegalovirus-positive antigenemia in orthotopic liver transplant patients.
    Hoppe L; Bressane R; Lago LS; Schiavo FL; Marroni CA; Keiserman DR; Brandão AB; Júnior AM; Cassal AP; Zanotelli ML; Cantisani GP
    Transplant Proc; 2004 May; 36(4):961-3. PubMed ID: 15194334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors associated with cytomegalovirus infection in orthotopic liver transplant patients.
    Hoppe L; Marroni CA; Bressane R; Lago L; Schiavo FL; Cigerza GC; Brandão AB; Zanotelli ML; Cantisani GP
    Transplant Proc; 2006; 38(6):1922-3. PubMed ID: 16908324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory bowel disease after liver transplantation: a role for cytomegalovirus infection.
    Verdonk RC; Haagsma EB; Van Den Berg AP; Karrenbeld A; Slooff MJ; Kleibeuker JH; Dijkstra G
    Scand J Gastroenterol; 2006 Feb; 41(2):205-11. PubMed ID: 16484126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk factors for cytomegalovirus syndrome and tissue-invasive cytomegalovirus disease in liver transplant recipients who have cytomegalovirus antigenemia.
    Kim JM; Kim SJ; Joh JW; Shin M; Moon JI; Jung GO; Choi GS; Kwon CH; Lee SK
    Transplant Proc; 2010 Apr; 42(3):890-4. PubMed ID: 20430198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for posttransplant lymphoproliferative disorder in pediatric liver transplant recipients with cytomegalovirus antigenemia.
    Kim JM; Lee SK; Kim SJ; Joh JW; Kwon CH; Choe YH; Shin M; Kim EY; Moon JI; Jung GO; Choi GS
    Transplant Proc; 2010 Apr; 42(3):895-9. PubMed ID: 20430199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HHV-6-DNAemia related to CMV-DNAemia after liver transplantation.
    Härmä M; Loginov R; Piiparinen H; Halme L; Höckerstedt K; Lautenschlager I
    Transplant Proc; 2005 Mar; 37(2):1230-2. PubMed ID: 15848678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive factors for cytomegalovirus infection after orthotopic liver transplantation using an ultrasensitive polymerase chain reaction assay.
    Basse G; Esposito L; Mengelle C; Kamar N; Ribes D; Lavayssière L; Pillet A; Suc B; Barange K; Rostaing L
    Transplant Proc; 2006 Sep; 38(7):2339-41. PubMed ID: 16980084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C.
    Burak KW; Kremers WK; Batts KP; Wiesner RH; Rosen CB; Razonable RR; Paya CV; Charlton MR
    Liver Transpl; 2002 Apr; 8(4):362-9. PubMed ID: 11965581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CMV hepatitis after liver transplantation: incidence, clinical course, and long-term follow-up.
    Seehofer D; Rayes N; Tullius SG; Schmidt CA; Neumann UP; Radke C; Settmacher U; Müller AR; Steinmüller T; Neuhaus P
    Liver Transpl; 2002 Dec; 8(12):1138-46. PubMed ID: 12474153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression.
    Hadley S; Samore MH; Lewis WD; Jenkins RL; Karchmer AW; Hammer SM
    Transplantation; 1995 Mar; 59(6):851-9. PubMed ID: 7535482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late cytomegalovirus disease following liver transplantation.
    Shibolet O; Ilan Y; Kalish Y; Safadi R; Ashur Y; Eid A; Shouval D; Wolf D
    Transpl Int; 2003 Dec; 16(12):861-5. PubMed ID: 12904846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of cytomegalovirus infection with human leukocyte antigen genotypes in recipients after allogeneic liver transplantation.
    Fan J; Meng XQ; Yang MF; Zhou L; Chen XM; Hu MJ; Fan WW; Ma WH; Li LJ
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):34-8. PubMed ID: 16481279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deferred versus prophylactic therapy with gancyclovir for cytomegalovirus in allograft liver transplantation.
    Lianghui G; Shusen Z; Tingbo L; Yan S; Weilling W; Anwei L
    Transplant Proc; 2004 Jun; 36(5):1502-5. PubMed ID: 15251371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical usefulness of human cytomegalovirus antigenemia assay after kidney transplantation.
    Kim CK; Song JH; Kim SM; Peck KR; Oh W; Huh W; Kim YG; Kim SJ; Joh JW; Lee NY; Park CG; Hwang ES; Cha CY; Oh HY
    Transplantation; 2003 Jun; 75(12):2151-5. PubMed ID: 12829929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Who among cytomegalovirus-seropositive liver transplant recipients is at risk for cytomegalovirus infection?
    Singh N; Wannstedt C; Keyes L; Wagener MM; Cacciarelli TV
    Liver Transpl; 2005 Jun; 11(6):700-4. PubMed ID: 15915496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus antigenemia and outcomes of patients undergoing allogeneic peripheral blood stem cell transplantation: effects of long-term high-dose acyclovir prophylaxis and preemptive ganciclovir treatment.
    Hazar V; Ugur A; Colak D; Saba R; Tezcan G; Kupesiz A; Karadogan I; Gultekin M; Yesilipek A; Undar L
    Jpn J Infect Dis; 2006 Aug; 59(4):216-21. PubMed ID: 16936338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for an increased rate of bacterial infections in liver transplant patients with cytomegalovirus infection.
    van den Berg AP; Klompmaker IJ; Haagsma EB; Peeters PM; Meerman L; Verwer R; The TH; Slooff MJ
    Clin Transplant; 1996 Apr; 10(2):224-31. PubMed ID: 8664524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus infection and development of biliary complications after liver transplantation.
    Halme L; Hockerstedt K; Lautenschlager I
    Transplantation; 2003 Jun; 75(11):1853-8. PubMed ID: 12811245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus infection of the liver transplant: virological, histological, immunological, and clinical observations.
    Lautenschlager I; Halme L; Höckerstedt K; Krogerus L; Taskinen E
    Transpl Infect Dis; 2006 Mar; 8(1):21-30. PubMed ID: 16623817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors of cytomegalovirus infection after living donor liver transplantation.
    Akamatsu N; Sugawara Y; Kaneko J; Kishi Y; Makuuchi M
    Hepatogastroenterology; 2005; 52(61):197-9. PubMed ID: 15783029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.